SG11201502089QA - Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer - Google Patents

Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Info

Publication number
SG11201502089QA
SG11201502089QA SG11201502089QA SG11201502089QA SG11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA SG 11201502089Q A SG11201502089Q A SG 11201502089QA
Authority
SG
Singapore
Prior art keywords
liver cancer
diagnosing liver
kit
subject
methods
Prior art date
Application number
SG11201502089QA
Other languages
English (en)
Inventor
Kam Man Hui
Original Assignee
Singapore Health Serv Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Singapore Health Serv Pte Ltd filed Critical Singapore Health Serv Pte Ltd
Publication of SG11201502089QA publication Critical patent/SG11201502089QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57438Specifically defined cancers of liver, pancreas or kidney
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SG11201502089QA 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer SG11201502089QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261704425P 2012-09-21 2012-09-21
PCT/SG2013/000414 WO2014046623A1 (fr) 2012-09-21 2013-09-23 Méthode de diagnostic du cancer du foie chez un sujet et kit permettant de diagnostiquer le cancer du foie

Publications (1)

Publication Number Publication Date
SG11201502089QA true SG11201502089QA (en) 2015-06-29

Family

ID=50341782

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201502089QA SG11201502089QA (en) 2012-09-21 2013-09-23 Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer

Country Status (7)

Country Link
US (1) US20150232943A1 (fr)
EP (1) EP2898099A4 (fr)
JP (1) JP2015530094A (fr)
KR (1) KR20150058465A (fr)
CN (1) CN104812914B (fr)
SG (1) SG11201502089QA (fr)
WO (1) WO2014046623A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101843173B1 (ko) * 2014-10-24 2018-03-29 씨비에스바이오사이언스 주식회사 혈관 내피 세포 성장인자 수용체 억제제에 대한 감수성 예측 방법
KR102116178B1 (ko) 2017-05-10 2020-05-27 서울대학교산학협력단 간암 고위험군의 간암 발병 모니터링 또는 진단용 바이오마커 및 그 용도
CN108048422A (zh) * 2017-11-30 2018-05-18 天津市湖滨盘古基因科学发展有限公司 一种gtp酶,imap家族成员7突变蛋白及其应用
CN110241198A (zh) * 2019-05-30 2019-09-17 成都吉诺迈尔生物科技有限公司 一种表征hHRD同源重组缺陷的基因组重组指纹及其鉴定方法
CN111610262A (zh) * 2020-05-19 2020-09-01 上海鹿明生物科技有限公司 一种用于肝胆疾病诊断的代谢标志物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1532268A4 (fr) * 2002-03-21 2006-07-05 Yissum Res Dev Co Marqueurs de cellules sanguines peripheriques utiles pour le diagnostic de la sclerose en plaques et procedes et trousses comprenant de tels marqueurs
EP1682904A2 (fr) * 2003-11-04 2006-07-26 Roche Diagnostics GmbH Methode pour distinguer des sous-types aml classes who
EP1830289A1 (fr) * 2005-11-30 2007-09-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Méthodes pour la classification et le pronostic du carcinome hépatocellulaire
WO2008138578A2 (fr) * 2007-05-11 2008-11-20 Medical Prognosis Institute Procédés, coffrets et dispositifs pour identifier des biomarqueurs de réponse à un traitement et utilisation de ceux-ci pour prédire l'efficacité du traitement
US8735082B2 (en) * 2008-11-10 2014-05-27 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Gene signature for predicting prognosis of patients with solid tumors

Also Published As

Publication number Publication date
CN104812914B (zh) 2020-07-24
WO2014046623A1 (fr) 2014-03-27
US20150232943A1 (en) 2015-08-20
EP2898099A1 (fr) 2015-07-29
KR20150058465A (ko) 2015-05-28
EP2898099A4 (fr) 2016-05-25
JP2015530094A (ja) 2015-10-15
CN104812914A (zh) 2015-07-29

Similar Documents

Publication Publication Date Title
HK1213947A1 (zh) 用於診斷甲狀腺腫瘤的組合物和方法
HK1205964A1 (en) Kit and devices for organ perfusion
PL2814959T3 (pl) Kompozycje i sposoby do dokładnej identyfikacji mutacji
EP2751748A4 (fr) Procédés et agencements d'identification d'objets
EP2776832A4 (fr) Biomarqueurs du cancer de la vessie et méthodes d'utilisation de ceux-ci
HK1210522A1 (en) Bladder cancer detection composition kit, and associated methods
ZA201805056B (en) Compositions and methods for identifying a risk of cancer in a subject
HK1259001A1 (zh) 癌症的預後和診斷方法
HK1214274A1 (zh) 用於治療肝臟疾病和心血管疾病的脂肽
LT2880180T (lt) Būdai ir rinkiniai, skirti vėžiu sergančių pacientų atrankai
HK1209832A1 (en) Method and kit for determination of free copper in serum
IL232466A0 (en) Preparations and methods for the analysis of prostate cancer
SG11201502089QA (en) Methods of diagnosing liver cancer in a subject and a kit for diagnosing liver cancer
PT2879715T (pt) Método e kit para preparação intestinal
EP2880443A4 (fr) Méthodes et compositions pour le diagnostic et le pronostic du cancer du sein
PL2561856T3 (pl) Sposób i zestaw do depilacji
PL2559421T3 (pl) Sposób i zestaw do depilacji
EP2740801A4 (fr) Procédé de mesure de sphingomyéline et trousse de mesure
SG11201501838RA (en) Completion assembly and methods for use thereof
EP2732287A4 (fr) Procédés de diagnostic du cancer
PL2517688T3 (pl) Sposób depilacji i zestaw do depilacji
EP2893042A4 (fr) Test de diagnostic de la démence et procédés associés
GB201201129D0 (en) Kit and method
GB201101021D0 (en) Kit and method
GB201120454D0 (en) Kit and uses thereof